Skip to content
healthcare.dev

Memantine Hydrochloride

NDC 16571-852, memantine, capsule, extended release, from Rising Pharma Holdings, Inc..

Product NDC
16571-852
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206032
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-852 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MEMANTINE HYDROCHLORIDE7 mg/1

Pharmacologic classes

N-methyl-D-aspartate Receptor Antagonist [EPC]; NMDA Receptor Antagonists [MoA]

Package NDCNDC-11Package
16571-852-031657108520330 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16571-852-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a282fbed-8304-458e-a0e9-5eaccc95339b
  • NADAC price for package 16571085203

    GET /v1/drugs/nadac/16571085203

Use it

Look up 16571-852 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-852 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-852. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.